Are the angiotensin-converting enzyme gene and activity risk factors for stroke?

Arq Neuropsiquiatr. 2006 Jun;64(2A):211-6. doi: 10.1590/s0004-282x2006000200008. Epub 2006 Jun 9.

Abstract

Stroke is a multifactorial disease in which genetic factors play an important role. This study was carried out to determine angiotensin-converting enzyme (ACE) gene polymorphism in Turkish acute stroke patients and to establish whether there is an association of angiotensin-converting enzyme gene I/D polymorphism with clinical parameters. In this study 185 patients and 50 controls were recruited. We have investigated the association among the allelic distribution of the insertion/deletion (I/D) polymorphism of the ACE gene identified by polymerase chain reaction. Distribution of ACE gene I/D genotypes and allele frequencies in patients were not significantly different from controls. D allele frequencies were 57.8% in patients versus 53.0% in controls and I allele 42.2% versus 47% respectively. History of hypertension, stroke, renal, heart and vessel diseases incidence and age, gender, systolic-diastolic blood pressures and creatinine levels were significantly high in patients. But these results and ACE activities had no significant differences among the ACE genotypes in patients and controls. Our results suggest that the ACE gene polymorphism is not associated with the pathogenesis of stroke in Turkish stroke patients.

MeSH terms

  • Acute Disease
  • Case-Control Studies
  • Female
  • Gene Frequency*
  • Genotype*
  • Humans
  • Male
  • Middle Aged
  • Peptidyl-Dipeptidase A / genetics*
  • Polymerase Chain Reaction
  • Polymorphism, Genetic / genetics*
  • Risk Factors
  • Stroke / enzymology*
  • Stroke / genetics

Substances

  • Peptidyl-Dipeptidase A